FDA Authorizes Pfizer/BioNTech COVID-19 Shot for Children

The FDA on Friday granted an updated Emergency Use Authorization (EUA) for the Pfizer/BioNTech COVID-19 vaccine for use in children ages five to 11 years — following a thumbs up from the agency’s expert advisory panel earlier in the week.
Source: Drug Industry Daily